Ace Therapeutics
Delivery System Development for the Treatment of Liver Disease
Get Free Quote

Delivery System Development for the Treatment of Liver Disease

Inquiry

Ace Therapeutics is an expert in the field of liver disease research. We have extensive research experience in the field of drug delivery in liver disease.

The goal of drug delivery is to enhance drug effectiveness and reduce off-target accumulation, which is what we strive for.

Delivery System Development for the Treatment of Liver Disease

What Can We Do?

Drug delivery technology has made possible the development of many drug products. It can maximize the effects of drug action and reduce off-target accumulation, thereby improving patient health. Therefore, we offer a wide range of targeted drug delivery services that combine the characteristics of different types of liver disease drugs.

The common targeted liver drug delivery systems include two main aspects, which are passive targeted liver drug delivery systems and active targeted liver drug delivery systems. The active targeted hepatic drug delivery systems include drug delivery systems targeting hepatic parenchymal cells, drug delivery systems targeting hepatic non-parenchymal cells, and drug delivery systems targeting hepatic tumor cells. We provide comprehensive development services for different targeted liver drug delivery systems.

Oligonucleotide drugs can interfere with the expression or translation process of target RNA by binding to the target RNA to achieve therapeutic purposes. Oligonucleotide drugs are characterized by long-lasting efficacy and high specificity. Therefore, they are effective in disease treatment. However, the delivery of oligonucleotide drugs is still a difficult task in the development process. We provide different delivery services for oligonucleotide characteristics.

Phages have many excellent properties, such as good biocompatibility, low side effects, easy biodegradability, and high loading capacity. This makes them a good complement to liposomes used for drug delivery.

Currently, phages have been widely used for the delivery of peptides, proteins, gene classes, and other drugs. In view of this, we offer comprehensive services to support phage delivery services for targeted liver diseases.

Exosomes can deliver different types of drugs, such as small molecules, proteins, and nucleic acids. Exosomes have many advantages as drug delivery vehicles, such as good biocompatibility, avoidance of phagocytosis by macrophages, and prolonged circulation in the body. In addition, exosome-based delivery not only delivers drugs to the damaged area but also exosomes themselves are rich in active molecules that can have a therapeutic effect.

Ace Therapeutics keeps up with the times and enriches its knowledge and technology to provide only the most scientific research services for targeted liver diseases. If you would like to learn more about our services, please feel free to contact us.

Our products and services are for research use only and can not be used for diagnostic or other purposes.